Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.45 |
| ▸ | NPC1 | O15118 | 4/20 | 0.45 |
| ▸ | TP53 | P04637 | 3/20 | 0.45 |
| ▸ | HPGD | P15428 | 3/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.45 |
| ▸ | RAB9A | P51151 | 2/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.44 |
| ▸ | JAK2 | O60674 | 1/20 | 0.43 |
| ▸ | JAK1 | P23458 | 1/20 | 0.43 |
| ▸ | TYK2 | P29597 | 1/20 | 0.43 |
| ▸ | JAK3 | P52333 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 3/20 | 0.43 |
| ▸ | CCR1 | P32246 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29496934 | 1.00 | ALOX5 (0.50) | ALOX5KDM4ESMN1; SMN2ALDH1A1NPC1 | |
| SCHEMBL483866 | 0.98 | ALOX5 (0.49) | ALOX5KDM4ESMN1; SMN2ALDH1A1NPC1 | |
| SCHEMBL30531494 | 0.98 | ALOX5 (0.49) | ALOX5KDM4ESMN1; SMN2ALDH1A1NPC1 | |
| SCHEMBL24793680 | 0.89 | MAOA (0.53) | ALOX5KDM4ESMN1; SMN2ALDH1A1NPC1 | |
| SCHEMBL24523701 | 0.89 | KDM4E (0.50) | KDM4ESMN1; SMN2ALDH1A1NPC1TP53 | |
| SCHEMBL24621709 | 0.89 | ALOX5 (0.47) | ALOX5KDM4ESMN1; SMN2ALDH1A1NPC1 | |
| SCHEMBL15696745 | 0.87 | KDM4E (0.40) | ALOX5KDM4ESMN1; SMN2ALDH1A1NPC1 | |
| SCHEMBL15672992 | 0.87 | KDM4E (0.41) | ALOX5KDM4ESMN1; SMN2ALDH1A1NPC1 | |
| SCHEMBL24523663 | 0.87 | ALOX5 (0.48) | ALOX5KDM4ESMN1; SMN2ALDH1A1NPC1 | |
| SCHEMBL26301593 | 0.86 | ALOX5 (0.43) | ALOX5KDM4ESMN1; SMN2ALDH1A1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 129 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4701391-A2 | HETEROLEPTIC IRIDIUM COMPLEX | Universal Display Corporation (US) | 2026-02-25 | — | — | EP | disclosed |
| US-12550604-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2026-02-10 | — | — | US | disclosed |
| US-12545698-B2 | Dinuclear platinum (II) red emitters for OLED applications | VERSITECH LIMITED (CN) | 2026-02-10 | — | — | US | disclosed |
| EP-3643721-B1 | HETEROLEPTIC IRIDIUM COMPLEX | UNIVERSAL DISPLAY CORP (US) | 2026-01-28 | — | — | EP | disclosed |
| US-12378468-B2 | Organometallic compound, organic light-emitting device including the same and electronic apparatus including the organic light-emitting device | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2025-08-05 | — | — | US | disclosed |
| US-12310229-B2 | Organometallic compound, organic light-emitting device including organometallic compound, and electronic apparatus including organic light-emitting device | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2025-05-20 | — | — | US | disclosed |
| US-20240324441-A1 | DINUCLEAR PLATINUM (II) RED EMITTERS FOR OLED APPLICATIONS | VERSITECH LIMITED (CN) | 2024-09-26 | — | — | US | disclosed |
| US-12069940-B2 | Organometallic compound, organic light-emitting device including the same and electronic apparatus including the organic light-emitting device | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2024-08-20 | — | — | US | disclosed |
| US-20240237507-A1 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG ELECTRONICS CO LTD (KR) | 2024-07-11 | — | — | US | disclosed |
| US-20240237507-A1 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG ELECTRONICS CO LTD (KR) | 2024-07-11 | — | — | US | disclosed |
| US-20120292601-A1 | PHOSPHORESCENT HETEROLEPTIC PHENYLBENZIMIDAZOLE DOPANTS AND NEW SYNTHETIC METHODOLOGY | UNIVERSAL DISPLAY CORPORATION (US) | 2012-11-22 | — | — | US | disclosed |
| US-20120292601-A1 | PHOSPHORESCENT HETEROLEPTIC PHENYLBENZIMIDAZOLE DOPANTS AND NEW SYNTHETIC METHODOLOGY | UNIVERSAL DISPLAY CORPORATION (US) | 2012-11-22 | — | — | US | disclosed |
| US-20120292601-A1 | PHOSPHORESCENT HETEROLEPTIC PHENYLBENZIMIDAZOLE DOPANTS AND NEW SYNTHETIC METHODOLOGY | UNIVERSAL DISPLAY CORPORATION (US) | 2012-11-22 | — | — | US | disclosed |
| WO-2012158851-A1 | PHOSPHORESCENT HETEROLEPTIC PHENYLBENZIMIDAZOLE DOPANTS AND NEW SYNTHETIC METHODOLOGY | UNIVERSAL DISPLAY CORPORATION (US) | 2012-11-22 | — | — | WO | disclosed |
| EP-2411401-A1 | HETEROLEPTIC IRIDIUM COMPLEX | Universal Display Corporation (US) | 2012-02-01 | — | — | EP | disclosed |
| US-20100244004-A1 | HETEROLEPTIC IRIDIUM COMPLEX | UNIVERSAL DISPLAY CORPORATION (US) | 2010-09-30 | — | — | US | disclosed |
| US-20100244004-A1 | HETEROLEPTIC IRIDIUM COMPLEX | UNIVERSAL DISPLAY CORPORATION (US) | 2010-09-30 | — | — | US | disclosed |
| US-20100244004-A1 | HETEROLEPTIC IRIDIUM COMPLEX | UNIVERSAL DISPLAY CORPORATION (US) | 2010-09-30 | — | — | US | disclosed |
| WO-2010111175-A1 | HETEROLEPTIC IRIDIUM COMPLEX | UNIVERSAL DISPLAY CORPORATION (US) | 2010-09-30 | — | — | WO | disclosed |
| WO-2010111175-A1 | HETEROLEPTIC IRIDIUM COMPLEX | UNIVERSAL DISPLAY CORPORATION (US) | 2010-09-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12378468-B2 | Organometallic compound, organic light-emitting device including the same and electronic apparatus including the organic light-emitting device | L1CAM, NOM1, MSL1 | ALOX5 2277/4885KDM4E 3473/4885SMN1; SMN2 1784/4885 |
| US-12310229-B2 | Organometallic compound, organic light-emitting device including organometallic compound, and electronic apparatus including organic light-emitting device | L1CAM, AP1M1, AP2M1 | ALOX5 2795/4885KDM4E 3988/4885SMN1; SMN2 1951/4885 |
| US-20240324441-A1 | DINUCLEAR PLATINUM (II) RED EMITTERS FOR OLED APPLICATIONS | OCIAD2, POF1B, OCIAD1 | ALOX5 3534/4885KDM4E 4246/4885SMN1; SMN2 3117/4885 |
| US-12069940-B2 | Organometallic compound, organic light-emitting device including the same and electronic apparatus including the organic light-emitting device | L1CAM, NOM1, MSL1 | ALOX5 2277/4885KDM4E 3473/4885SMN1; SMN2 1784/4885 |
| US-20120292601-A1 | PHOSPHORESCENT HETEROLEPTIC PHENYLBENZIMIDAZOLE DOPANTS AND NEW SYNTHETIC METHODOLOGY | POF1B, OCIAD1, OCIAD2 | ALOX5 301/4885KDM4E 2307/4885SMN1; SMN2 2007/4885 |
| US-12545698-B2 | Dinuclear platinum (II) red emitters for OLED applications | OPRD1, POF1B, OCIAD2 | ALOX5 3150/4885KDM4E 4302/4885SMN1; SMN2 3075/4885 |
| US-20240237507-A1 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE | L1CAM, MSL1, EML4 | ALOX5 2420/4885KDM4E 3100/4885SMN1; SMN2 1542/4885 |
| US-20100244004-A1 | HETEROLEPTIC IRIDIUM COMPLEX | DDT, ICOSLG, PDCD1LG2 | ALOX5 680/4885KDM4E 3232/4885SMN1; SMN2 3234/4885 |
| US-12550604-B2 | Organic electroluminescent materials and devices | ROS1, DNMT3A, PRDM9 | ALOX5 3699/4885KDM4E 299/4885SMN1; SMN2 3484/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.